Exelixis throws in the towel on early-stage liver cancer after final reading shows OS flop –…
The door to a label expansion for Exelixis' Cabometyx is now completely closed.
Exelixis held out a glimmer of hope – however slim – in the summer of last year, when it published mixed results from an interim…